secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001171843-26-001614
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience posts March 2026 investor presentation; no specific new data in excerpt
--------------------------------------------------------------------------------

- Filing attaches corporate slide deck dated March 2026; only cover page and forward-looking statement provided.
- No financial results, guidance changes, or material events disclosed in the 8-K or exhibit excerpt.
- Presentation is routinely updated for investor conferences; full content not visible in this filing.
- Investors should review complete presentation for any operational or strategic updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326001614/0001171843-26-001614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326001614/f8k_031726.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer